Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-13
2009-12-22
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S358000
Reexamination Certificate
active
07635697
ABSTRACT:
Disclosed are compounds of the Formula:wherein the substituents are as defined herein. Also disclosed are uses of the compounds of formula 1.0 for the manufacture of a medicament for treating cancer and for inhibiting farnesyl protein transferase.
REFERENCES:
patent: 5801175 (1998-09-01), Afonso et al.
patent: 6214827 (2001-04-01), Afonso et al.
patent: 2006/0154937 (2006-07-01), Rane
patent: 2007/0213340 (2007-09-01), Kelly et al.
patent: WO 98/57960 (1998-12-01), None
patent: WO 00/37458 (2000-06-01), None
patent: WO 00/37459 (2000-06-01), None
patent: WO 02/056884 (2002-07-01), None
patent: WO 02/080895 (2002-10-01), None
patent: WO 03/072549 (2003-09-01), None
Saba et al. Expert Opinion in Investigational Drugs, 2004, 13(6), 609-29.
Banerji et al. Expert Opinion in Therapeutic Targets, 2004, 8(3), 221-39.
PCT International Search Report dated Apr. 4, 2006 for counterpart PCT Application No. PCT/US2005/045019.
Schering-Plough Discontinues Phase III Clinical Study of Sarasar(TM) (Lonafarnib) in Non-Small-Cell Lung Cancer, Schering-Plough Press Release, Feb. 5, 2004.
Jarrell Noble
Jeanette Henry C.
Schering Corporation
Wilson James O
LandOfFree
Farnesyl protein transferase inhibitors and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Farnesyl protein transferase inhibitors and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Farnesyl protein transferase inhibitors and methods for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4147628